EcoDrugPlus

Checkpoint Kinase 2

Ensembl ID : ENSCCRG00000038583
Gene Symbol: CHEK2
1 Cross references
203 Possible Orthologues:

Chemokine (C-C Motif) Receptor 9a

Ensembl ID : ENSCCRG00000051761
Gene Symbol: CCR9A
1 Cross references
186 Possible Orthologues:

Chemokine (C-C Motif) Receptor 9a

Ensembl ID : ENSCCRG00000065936
Gene Symbol: CCR9A
1 Cross references
187 Possible Orthologues:

Chemokine (C-X-C Motif) Receptor 4a

Ensembl ID : ENSCCRG00000047765
Gene Symbol: CXCR4A
1 Cross references
199 Possible Orthologues:

Chemokine (C-X-C Motif) Receptor 4a

Ensembl ID : ENSCCRG00000054142
Gene Symbol: CXCR4A
1 Cross references
199 Possible Orthologues:

Chemokine (C-X-C Motif), Receptor 4b

Ensembl ID : ENSCCRG00000042027
Gene Symbol: CXCR4B
1 Cross references
201 Possible Orthologues:

Chemokine (C-X-C Motif), Receptor 4b

Ensembl ID : ENSCCRG00000058981
Gene Symbol: CXCR4B
1 Cross references
202 Possible Orthologues:

Cholecystokinin A Receptor

Ensembl ID : ENSCCRG00000002393
Gene Symbol: CCKAR
1 Cross references
198 Possible Orthologues:

Cholecystokinin A Receptor

Ensembl ID : ENSCCRG00000034676
Gene Symbol: CCKAR
1 Cross references
198 Possible Orthologues:

Cholecystokinin B Receptor A

Ensembl ID : ENSCCRG00000020448
Gene Symbol: CCKBRA
1 Cross references
195 Possible Orthologues:

Cholecystokinin B Receptor A

Ensembl ID : ENSCCRG00000020400
Gene Symbol: CCKBRA
1 Cross references
195 Possible Orthologues:

Cholesteryl Ester Transfer Protein, Plasma

Ensembl ID : ENSCCRG00000037266
Gene Symbol: CETP
1 Cross references
151 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).